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We report a case of bilateral atrophic retinochoroidopathy with choroidal neovascular 
membrane (CNVM) formation in a patient with systemic Langerhans cell histiocytosis (LCH). 
A 35-year-old female, diagnosed with LCH at the age of 3, experienced an episode of acute 
vision loss in her right eye. Visual acuity was counting fingers. Dilated fundus exam and 
fluorescein angiography revealed the presence of CNVM along with bilateral widespread 
areas of chorioretinal atrophy. The patient underwent removal of CNVM with excellent 
postoperative visual acuity (20/25); however, indolent progression of her disease led to 
gradual deterioration of visual acuity (20/80 in the right eye and 20/320 in the left). This case 
shows that in contrast to previous reports, intraocular involvement of LCH does not need to 
be dramatic and clinically evident but it can acquire a chronic degenerative form. This report 
aims to raise awareness among ophthalmologists concerning the potential intraocular 
sequelae of LCH. 
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Langerhans cell histiocytosis (LCH), formerly known as histiocytosis X, encompasses 
a wide spectrum of diseases seen in children and young adults, which are characterized 
by the abnormal proliferation of cells with Langerhans cell characteristics. Terms such 
as Letterer-Siwe disease, Hand-Schüller-Christian syndrome and eosinophilic 
granuloma refer to various clinical syndromes of LCH mostly now of historical 
significance. Although the underlying pathophysiology is still unclear, there is evidence 
to suggest a cytokine-mediated process. Bone, skin, lungs and lymph nodes are 
frequently affected. Ophthalmic involvement is seen in 10–23% of patients, most often 
involving the soft tissues of the orbit resulting in proptosis [1]. Intraocular involvement 
is rare and has been reported both as an isolated focus [2] or as diffuse inflitrative 
disease [3]. 
We report here the first case, to our knowledge, of an adult patient with LCH and 
bilateral atrophic retinochoroidopathy with development of choroidal neovascular 
membrane (CNVM). Despite successful removal of CNVM with submacular surgery and 
stable good vision for almost 6 years, subsequent slow progression of the disease led to 
bilateral visual disability. 
Case Report 
In 1978, disseminated LCH was diagnosed in a 3-year-old girl involving the skull, central nervous 
system (CNS) and lower extremities. Despite being critically ill for several months, supportive care 
resulted in near complete recovery. No systemic chemotherapy was administered. Cerebellar 
disturbance manifesting as ataxia and dizziness were residual symptoms from CNS involvement by 
the disease. 
At 23 years of age (October 1998), the patient presented to our clinic complaining of decreased 
vision in her right eye. Visual acuity was counting fingers in the right eye and 20/25 in the left eye. 
Dilated fundus examination was significant for bilateral symmetric widespread areas of pigmentary 
disturbance and chorioretinal atrophy. These areas were well demarcated, punched out, and located 
at the posterior pole involving the macula and perimacular area (fig. 1a, b). There was mild 
peripapillary atrophy in both eyes. The anterior chamber and vitreous were clear in both eyes. No 
signs of active inflammation were present. There was no relative afferent pupillary defect. Fluorescein 
angiography revealed the presence of CNVM in the right eye along with blockage of fluorescence 
corresponding to the areas of atrophy with late staining at their edges (fig. 1c, d). 
The patient underwent extraction of the CNVM by subretinal surgery. There were no 
intraoperative complications. 
Results 
In January 1999, three months after surgery, the patient’s visual acuity improved 
from counting fingers at initial presentation to 20/25 and remained stable for the next 
5 years. An extensive work-up to identify the etiology of the bilateral chorioretinal 
atrophic areas was undertaken: CBC, ESR, ACE, RPR, FTA-ABS, HIV, hepatitis B and C, 
HSV, as well as chest X-ray were all normal. Further testing for toxoplasmosis and 
tuberculosis was also noncontributory. The patient did not have any history of in utero 
infections, or any history of histoplasmosis exposure. Past medical history was 
insignificant other than LCH. There was no history of trauma or use of tobacco. The  
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patient did not have hypertension or any type of diabetes. No medications were 
prescribed after resolution of LCH symptoms and the disease was in remission ever 
since that initial episode at the age of 3. There was no other significant past ocular 
history nor any family history of eye disease. 
In 2005, the patient started to complain of increasing dyschromatopsia in both eyes 
and increased number of dark spots in her right central visual field. Ishihara plate 
reading was 0/8 for the right eye and 1/8 for the left. Fluorescein and ICG angiography 
did not reveal the recurrence or new development of a CNVM, nor any signs of active 
disease that could explain these symptoms. Goldman visual fields (GVF) in the right eye 
revealed a relative and absolute central scotoma, which was attributed to scarring. GVF 
on the left was normal. On March 2007, visual acuity has deteriorated to 20/80 in the 
right eye and 20/160 in the left eye. Dilated fundus examination, fluorescein and ICG 
angiography (fig. 1g, h) did not reveal any significant fundus changes or any areas of 
new inflammatory involvement from her last exam and a plausible explanation for this 
decline of vision was not identified. Cirrus spectral-domain optical coherence 
tomography (SD-OCT, Cirrus, Zeiss) images (fig. 2) were significant for areas of outer 
retinal irregularity, RPE elevation and chorioretinal scarring. Visual acuity in the left 
eye continued to decline until her last visit on March 2009 when it was 20/320, 
compared to that of the right eye which remained stable at 20/80. 
Discussion 
Intraocular involvement in LCH is rare. A review of the literature (table 1) indicates 
that the disease can affect multiple structures within the eye, with choroid being the 
most common among them. Choroidal involvement may present either in a diffuse 
infiltrative pattern or as a solitary mass lesion. Aberrant infiltration of abnormal 
Langerhans cells has been histologically identified in the retina [4], vitreous, sclera [5], 
aqueous humor [6] and optic nerve sheath [7]. From the reported cases with 
intraocular involvement, the majority of patients (10/15) were less than 10 years old 
with concurrent multisystemic disease involving either the spleen, lymph nodes, skin, 
bones and liver [3–11]. The risk of progression to an unfavorable visual outcome is 
very high when diffuse infiltration is present. In adults there have been 5 cases 
reported. Tsai et al. [12] reported of an 18-year-old male with reactivation of LCH and 
concurrent anterior uveitis with iris nodules. This is the only case demonstrating 
anterior uveal tract involvement without evidence of disease in the posterior segment 
of the eye. Patton et al. [13] reported of a 29-year-old man who presented with a 
choroidal mass several years after resection of a solitary cerebral LCH lesion. Diffuse 
infiltration of ocular tissues by proliferating histiocytes in adults is rare and only one 
case has been demonstrated to date in a patient with aggressive multisystemic LCH 
[14]. Intraocular involvement as the single manifestation of LCH is extremely rare and 
only 2 cases have been reported thus far [2, 15]. Interestingly, both cases presented in 
adults as a solitary choroidal mass. Cancer-associated retinopathy as a result of 
systemic LCH has also been recently reported in a 3-year-old patient [16]. 
The differential diagnosis of bilateral chorioretinal scars with or without CNVM 
formation is extensive and includes both infectious causes and inflammatory 
retinochoroidopathies, such as punctate inner choroidopathy (PIC), multifocal  
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choroiditis with panuveitis (MCP) and serpiginous choroidopathy, among others. 
However, along with our patient’s negative work-up, no criteria were met to support 
the diagnosis of any of these entities. More precisely, the patient never had any vitreous 
cells, which is considered a sine qua non for MCP diagnosis. Furthermore, the multifocal 
and symmetric distribution of the lesions was unlikely to be consistent with MCP or 
serpiginous choroidopathy. The patient did not have any myopia to support a diagnosis 
of PIC. 
Our patient presented at the age of 23 with bilateral atrophic chorioretinal scars, 
which indicated that the initial inflammatory insult occurred before her first visit in 
October 1998. Considering the negative past ocular history, the unremarkable 
laboratory work-up and her systemic disease at the age of 3, we concluded that 
disseminated LCH was responsible for the observed fundus abnormalities. Our 
diagnosis was further supported by the fact, that similar fundus findings have been 
reported by Epstein and Grant [6] in a case of a 5-month-old child with disseminated 
LCH. The authors described multiple round symmetrical punched-out choroidal lesions 
in both eyes. Additionally, another report from François and Bacskulin [10] described 
an 8-year-old child with disseminated LCH who developed bilateral circular pigmented 
areas as well as areas of depigmentation in the posterior pole. In both of these cases 
and the vast majority of pediatric LCH cases, aggressive disease progression led to 
acute severe vision loss. In our case, however, initial eye involvement was mild and 
remained asymptomatic, led to the development of the choroidal atrophic spots after 
the disease subsided and became symptomatic 20 years later with the development of 
CNVM. A possible explanation for this phenotypic clinical variation is that the severity 
and extent of inflammation was milder in our patient compared to the reported cases. 
Finally, our patient experienced a gradual deterioration of visual acuity over the years, 
which can be attributed to slow progression of the disease. Comparison of the fundus 
photographs and fluorescein angiographies obtained from our patient’s visits revealed 
mild enlargement in the size and pigmentation of the atrophic scars over the years (fig. 
1a, b, i, j). 
In summary, this rare case illustrates that intraocular involvement in LCH does not 
need to be dramatic and clinically evident, leading to acute vision loss as previously 
reported but it can have a more chronic degenerative course. This case report 
underlines the importance of a fundus examination in children with multisystemic LCH. 
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Table 1. Previously reported cases of Langerhans cell histiocytosis 
               
                No.  Authors  Year  Age  Sex  Manifestations/findings  Comment/outcome  Ref. 
                               
Reports in children 
01  Boztug et al.  2006  Neonate  F  Bilateral diffuse infiltration of histiocytes  Multisystemic LCH – bilateral total 
vision loss 
03 
02  Lahav and Albert  1974  Neonate  M  Bilateral diffuse infiltration of uveal tract and 
optic nerve sheath – iris nodules 
Multisystemic LCH – patient 
succumbed to the disease 
07 
03  Rupp and Holloman  1970  03  
months 
F  Bilateral iris nodules and diffuse infiltration of 
the choroid 
Multisystemic LCH – patient 
succumbed to disease 
08 
04  Epstein and Grant  1977  09  
months 
F  Bilateral multiple punched out choroidal 
lesions – secondary open-angle glaucoma 
Multisystemic LCH – enucleation 
of the left eye 
06 
05  Heath  1959  16  
months 
M  Bilateral diffuse infiltration of sclera, uveal tract 
retina and vitreous 
Multisystemic LCH – patient 
succumbed to the disease 
05 
06  Mozziconacci et al.  1966  02   F  Severe retinal and vitreous involvement  Multisystemic LCH – bilateral total 
vision loss 
04 
07  Hayashi et al.  2007  03   F  Cancer-associated retinopathy – no intraocular 
infiltration of histiocytes 
Multisystemic LCH – successfully 
treated with chemotherapy 
16 
08  Angell and Burton  1978  05   F  Unilateral choroidal mass  Multisystemic LCH – in remission  09 
09  François and 
Bacskulin 
1967  08   M  Bilateral circular pigmented areas as well as 
areas of depigmentation in the posterior pole – 
tapetoretinal degeneration of ocular fundi 
Multisystemic LCH – bilateral 
severe vision loss 
10 
10  Mittelman et al.  1973  03   M  Bilateral diffuse choroidal infiltration, extensive 
retinal degeneration and loss of photoreceptors 
Multisystemic LCH – patient 
succumbed to the disease 
11 
    Reports in adults 
11  Tsai et al.  2005  18  M  Unilateral anterior uveitis and iris nodules  Multisystemic LCH – successfully 
treated with topical corticosteroids 
12 
12  Patton et al.  2006  29  M  Intraocular choroidal mass  Presumed diagnosis after 
documented solitary cerebral LCH 
lesion – treated successfully with 
external beam radiotherapy 
13 
13  MacCumber et al.  1990  43  M  Histiocytic infiltration of choroid, sclera, optic 
nerve 
Multisystemic LCH – patient 
succumbed to the disease 
14 
    Intraocular unifocal LCH 
14  Kim and Lee  2000  49  M  Solitary choroidal tumor  No systemic findings – involved 
eye was enucleated 
15 
15  Narita et al.  1993  61  F  Solitary tumor, anterior uveitis, diffuse 
infiltration of intraocular tissues by histiocytes 
No systemic findings – involved 
eye was enucleated 
02 





Case Rep Ophthalmol 2012;3:128–135 
DOI: 10.1159/000338189 
Published online: 
April 13, 2012 








Fig. 1. a–d October 1998. Red-free fundus photographs (a, b) demonstrating the widespread areas of 
atrophy in both eyes. Early (c) and late (d) phase fluorescein angiography of the right eye reveals the 
presence of choroidal neovascular membrane. September 2001. Color fundus photographs (e, f) 
showing multiple areas of pigmentary changes. March 2007. ICG angiography shows multiple 
scattered hypofluorescent spots without any signs of new inflammatory involvement (g, h). April 
2009. Comparison of the red free photographs taken from patient’s initial (a, b) and last follow-up 
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Fig. 2. Imaging with Cirrus SD-OCT reveals hyper-reflective areas of outer retinal irregularity (f, 
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